Olympus Corporation of the Americas has signed a definitive agreement to acquire healthcare systems integrator, Image Stream Medical, for a purchase consideration of up to $87m.
Image Stream will become a fully owned subsidiary of Olympus and continue to operate with the same name.
Go deeper with GlobalData
The acquisition, which will be effective from June this year, will enable both the companies to further improve clinical outcomes, reduce overall costs, and enhance quality of life for patients.
Straumann Holding has completed the acquisition of an additional 18% stake in dental device company, RODO Medical, bringing its total share in the company to 30%.
Straumann earlier acquired 12% stake in RODO in August 2014.
Span-America Medical Systems will be acquired by Savaria (SC) Inc, a wholly owned subsidiary of Savaria Corporation, for a purchase consideration of $80.2m.
The target company manufactures and markets pressure management and patient positioning products, while the acquirer company is a manufacturer of accessibility equipment such as stair lifts, wheelchair lifts, and elevators.
Following the transaction, Savaria’s subsidiary will merge with Span-America, which will continue as a wholly owned indirect subsidiary of Savaria.
Healthcare service company Owens and Minor have signed a definitive purchase agreement to purchase medical supplies distributor, Byram Healthcare Centers (Byram), for $380m in cash.
The target company is engaged in distributing reimbursable medical supplies to home patients and home health agencies in the US.
The acquisition, which is expected to be closed in Q3 2017, will enable Owens and Minor to expand its reach beyond the hospital setting all the way to the patient's home.
LivaNova has completed the acquisition of the remaining 51% stake in Caisson Interventional for a purchase consideration of up to $72m.
The acquirer company is a developer of medical equipment for cardiac surgery, neuro-modulation and cardiac rhythm management, while the target company designs, develops and evaluates novel percutaneous mitral valve replacement systems.
The firm expects the acquisition to help strengthen its heart team physicians portfolio.
